subject area of
- Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 Journal Articles
- Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials Journal Articles
- Antiretroviral Drug Concentrations in Breastmilk, Maternal HIV Viral Load, and HIV Transmission to the Infant: Results From the BAN Study Journal Articles
- Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis Journal Articles
- Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)* Journal Articles
- Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo Journal Articles
- Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis Journal Articles
- Drug treatments for covid-19: living systematic review and network meta-analysis Journal Articles
- Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs Journal Articles
- Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19 Journal Articles
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis Journal Articles
- Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial Journal Articles
-
Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with
HIV and hepatitis C Journal Articles - How trustworthy guidelines can impact outcomes Journal Articles
- Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen Journal Articles